Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 5,596	$ 4,828
Accounts receivable	4,715	5,032
Other current assets	2,173	2,294
Total current assets	12,484	12,154
Property and equipment, net	506	480
Other intangible assets, net	544	861
Operating lease right of use assets	2,298	2,439
Other long-term assets	45	45
Total assets	15,877	15,979
Current liabilities:
Accounts payable	1,582	1,050
Accrued salary and bonus	888	1,456
Other accrued expenses	8,323	8,419
Line of credit - current	2,200	2,500
Current liabilities of discontinued operations	858	858
Total current liabilities	13,851	14,283
Contingent consideration	368	518
Operating lease liabilities, net of current portion	1,748	1,848
Note payable at fair value	11,132	11,165
Other long-term liabilities	4,780	4,701
Total liabilities	31,879	32,515
Commitments and contingencies (Note 9)
Redeemable preferred stock, $.01 par value; 5,000,000 shares authorized, 47,000 shares Series B issued and outstanding	46,536	46,536
Stockholders’ deficit:
Common stock, $.01 par value; 100,000,000 shares authorized; 4,390,826 and 4,367,830 shares issued, respectively; 4,311,414 and 4,296,710 shares outstanding, respectively	405	405
Additional paid-in capital	187,708	187,516
Accumulated deficit	(248,666)	(249,017)
Treasury stock, at cost (79,412 and 71,120 shares, respectively)	(1,985)	(1,976)
Total stockholders’ deficit	(62,538)	(63,072)
Total liabilities and stockholders’ deficit	(30,659)	(30,557)
Total liabilities, preferred stock and stockholders’ deficit	$ 15,877	$ 15,979